Background: Dendritic cells (DC) and tumour-associated macrophages (TAM) are essential in linking the innate and adaptive immune response against tumour cells and tumour progression. These cells are also potential target for immunotherapy as well as providing a handle to investigate immune status in the tumour microenvironment. The aim of the present study was to examine their impact on prognosis and chemotherapy response in periampullary adenocarcinoma, including pancreatic cancer, with particular reference to morphological subtype. Methods: The density of tolerogenic immature CD1a+ dendritic cells (DC), and MARCO+, CD68+ and CD163+ tissue-associated macrophages (TAM) was analysed by immunohistochemistry in tissue micro arrays with tumours...
Tumor microenvironment is composed of tumor cells, fibroblasts, and infiltrating immune cells, which...
Over the past decade, researchers have identified and characterized the diverse cell populations wit...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor and is insensitive to radiothera...
Background: Dendritic cells (DC) and tumour-associated macrophages (TAM) are essential in linking th...
Background: Natural killer (NK) cells and NK T cells (NKT) are vital parts of tumour immunosurveilla...
OBJECTIVE: Tumour-associated macrophages (TAMs) play key roles in tumour progression. Recent eviden...
Additional file 1. Associations between CD1a+ DC-cell infiltration and clinicopathological factors
In patients with pancreatic ductal adenocarcinoma (PDAC), the tumor microenvironment consists of cel...
Background: Periampullary adenocarcinomas are a heterogenous group of tumours with poor prognosis th...
Background: The clinical management of pancreatic and other periampullary neoplasms remains challeng...
Monocytes and macrophages make up part of the innate immune system and provide one of the first defe...
Additional file 4. Associations between MARCO+ infiltration and clinicopathological factors
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a 5-year survival ra...
Background: Immune cells interact not only with tumor cells but also with stromal cells facilitating...
Dendritic cells (DC) are an integral part of the tumor microenvironment. Pancreatic cancer is charac...
Tumor microenvironment is composed of tumor cells, fibroblasts, and infiltrating immune cells, which...
Over the past decade, researchers have identified and characterized the diverse cell populations wit...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor and is insensitive to radiothera...
Background: Dendritic cells (DC) and tumour-associated macrophages (TAM) are essential in linking th...
Background: Natural killer (NK) cells and NK T cells (NKT) are vital parts of tumour immunosurveilla...
OBJECTIVE: Tumour-associated macrophages (TAMs) play key roles in tumour progression. Recent eviden...
Additional file 1. Associations between CD1a+ DC-cell infiltration and clinicopathological factors
In patients with pancreatic ductal adenocarcinoma (PDAC), the tumor microenvironment consists of cel...
Background: Periampullary adenocarcinomas are a heterogenous group of tumours with poor prognosis th...
Background: The clinical management of pancreatic and other periampullary neoplasms remains challeng...
Monocytes and macrophages make up part of the innate immune system and provide one of the first defe...
Additional file 4. Associations between MARCO+ infiltration and clinicopathological factors
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a 5-year survival ra...
Background: Immune cells interact not only with tumor cells but also with stromal cells facilitating...
Dendritic cells (DC) are an integral part of the tumor microenvironment. Pancreatic cancer is charac...
Tumor microenvironment is composed of tumor cells, fibroblasts, and infiltrating immune cells, which...
Over the past decade, researchers have identified and characterized the diverse cell populations wit...
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor and is insensitive to radiothera...